Ignacio J. Cas-Dei
Buenos Aires, C, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Association between pediatric counseling and after school physical activity in children: A cross-sectional study.
Journal: Archivos argentinos de pediatria
Published: August 25, 2026
Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry.
Journal: Dermatology and therapy
Published: April 20, 2026
Sustained Effectiveness of Secukinumab Across Different Body Regions in Patients with Moderate-to-Severe Plaque Psoriasis from the PURE Registry.
Journal: Dermatology and therapy
Published: October 06, 2022
Effectiveness and Safety of Secukinumab in Latin American Patients with Moderate to Severe Plaque Psoriasis: PURE Registry 12-Month Data.
Journal: Dermatology and therapy
Published: September 09, 2022
Secukinumab long-term efficacy and safety in psoriasis through to year 5 of treatment: results of a randomized extension of the phase III ERASURE and FIXTURE trials.
Journal: The British journal of dermatology
Published: January 05, 2022
Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index.
Journal: Scientific reports
Published: January 24, 2020
Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
Journal: BMC dermatology
Published: July 16, 2018
Infectious skin disorders encountered in a pediatric emergency department of a tertiary care hospital in Argentina: a descriptive study.
Journal: International journal of dermatology
Published: March 31, 2018
Erratum to: Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.
Journal: Advances in therapy
Published: June 08, 2017
Secukinumab is Efficacious and Safe in Hispanic Patients with Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of Four Phase 3 Trials.
Journal: Advances in therapy
Published: February 20, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026